• Nanion Technologies: イオンチャネル研究のスマートツール

    Nanion Technologies: イオンチャネル研究のスマートツール

  • SyncroPatch 384i: HTS Automated Patch Clamp

    SyncroPatch 384i: HTS Automated Patch Clamp

  • SURFE²R 96SE: ラベルフリーのトランスポーターHTS

    SURFE²R 96SE: ラベルフリーのトランスポーターHTS

  • Dynamic Clamp: Patchliner

    Dynamic Clamp: Patchliner

  • 脂質二分子膜実験: Orbitシリーズ

    脂質二分子膜実験: Orbitシリーズ

  • CardioExcyte 96 SOL: 心筋の光ペーシング

    CardioExcyte 96 SOL: 心筋の光ペーシング

Our Product Portfolio

SyncroPatch 384

SyncroPatch 384

Patchliner

Patchliner

Port-a-Patch

Port-a-Patch

Port-a-Patch mini

Port-a-Patch mini

CardioExcyte 96

CardioExcyte 96

FLEXcyte 96

FLEXcyte 96

SURFE²R 96SE

SURFE²R 96SE

SURFE²R N1

SURFE²R N1

Orbit 16 TC

Orbit 16 TC

Orbit Mini

Orbit Mini

Vesicle Prep Pro

Vesicle Prep Pro

innoVitro - Statement about FLEXcyte technology

Icon FLEX  “We have been working with Nanion for several years on technology development projects and joint commercialization. Nanion is a prime example of an agile approach and customer orientation.”

Dr. Matthias Gossmann
co-founder and CEO at innoVitro, Germany. (CRO, FLEXcyte Service Provider)

Icon FLEX  “Human iPSC-derived cardiomyocytes are the future of safe and efficient drug development. The FLEXcyte technology provides a tool for functional cardiac toxicology and efficacy screening on these cells. Force-frequency relation are the subject of current scientific discussions and require an assay technology that can accurately quantify them and we meet this need with the FLEXcyte 96.

Dr. Peter Linder
CTO innoVitro, Germany. (CRO, FLEXcyte Service Provider)

We use cookies on our website. Some of them are essential for the operation of the site, while others help us to improve this site and the user experience (tracking cookies). You can decide for yourself whether you want to allow cookies or not. Please note that if you reject them, you may not be able to use all the functionalities of the site.